A Phase III, randomised, Open-Label, multicenter study evaluating the efficacy and safety of adjuvant GDC-9545 compared with physician's choice of adjuvant endocrine Monotherapy in patiens with Estrogen Receptor−Positive, HER2-NegativeEarly Breat Cancer - Project - Authors - KSSG Research Database

Project

A Phase III, randomised, Open-Label, multicenter study evaluating the efficacy and safety of adjuvant GDC-9545 compared with physician's choice of adjuvant endocrine Monotherapy in patiens with Estrogen Receptor−Positive, HER2-NegativeEarly Breat Cancer

Ongoing - recruitment closed · 2022 until 2030

Huober Jens, Sennhauser Andrina, Quinter Janine

Huober, Jens

chief physician
Brustzentrum St.Gallen, Medizinische Onkologie und Hämatologie · Dept. IV, Dept. I

Sennhauser, Andrina

study nurse
Medizinische Onkologie und Hämatologie · Dept. I

Quinter, Janine

Medizinische Onkologie und Hämatologie · Dept. I